Advancement of New Drug/Biomarker Discovery for Treatment of Diabetes

As a prognostic biomarker for progression of diabetic nephropathy, albuminuria fails in terms of sensitivity and specificity. Better urinary or plasma biomarkers are needed that can predict which diabetic patients are at highest risk for progression. Bhensdadia et al. report proteomic investigations that identified urinary haptoglobin as a potential prognostic biomarker for progressive diabetic nephropathy. Although as a single marker urinary haptoglobin adds little to albuminuria, together the two appear to provide better diagnostic accuracy than albuminuria alone. Excess adiposity is the most important risk factor for the development of insulin resistance and type 2 diabetes (1). However, mechanisms whereby body fat induces insulin resistance in distant tissues are not well understood. Recent evidence indicates that obesity may be an inflammatory markers.
  • Prognostic biomarkers
  • Diabetic nephropathy biomarkers
  • Diabetes: Clinical trials and new biomarkers under development
  • Pharmacotherapy in treatment of diabetes
  • Molecular markers for both metabolic syndrome and hypoglycemia responses
  • Inflammatory markers: Type 2 diabetes
  • New drug treatments and devices for diabetes: current research

Related Conference of Advancement of New Drug/Biomarker Discovery for Treatment of Diabetes

November 21-22, 2018

14th World Congress on Endocrinology & Diabetes

Paris, France
November 26-27, 2018

26th International Diabetes and Healthcare Conference

Helsinki, Finland
November 26-27, 2018

13th European Diabetes and Endocrinology Congress

Dublin, Ireland
February 27-28, 2019

Asia Pacific Diabetes and Endocrinology Congress

Radisson Hotel Narita, Tokyo, Japan

April 17-18, 2019

21st Asia Pacific Diabetes Conference

Osaka,Japan
May 17-18, 2019

2nd Global Experts Meeting on Diabetes, Hypertension & Metabolic Syndrome

Holiday Inn Singapore Atrium | Singapore
May 30-31, 2019

2nd Global Meeting on Diabetes and Endocrinology

Istanbul, Turkey
June 10-11, 2019

28th European Diabetes Congress

| Edinburgh, Scotland
July 24-25, 2019

29th World Diabetes & Heart Congress

Melbourne, Australia
July 29-30, 2019

12th International Conference on Diabetes & Metabolism

Chicago | Illinois| USA
Oct 03-04, 2019

Euro Diabetes Congress & Expo

| Paris, France

Advancement of New Drug/Biomarker Discovery for Treatment of Diabetes Conference Speakers

Recommended Sessions

Related Journals

Are you interested in